1 month PFE Gets FDA Nod for Expanded Use of RSV Vaccine AbrysvoZacks

The FDA approves Pfizer’s RSV vaccine, Abrysvo, for adults aged 18-59 years with increased risk of the disease.

Pfizer (PFE)

17 hours Pharma Stock Roundup: EU Nod for PFE’s Hympavzi, NVS Ups Sales ViewZacks X

19 hours Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X

2 days Pfizer: High Dividend And Low Price Might Still Offset The Expanding RisksSeeking Alpha X

2 days PFE vs. NVO: Which Stock Is the Better Value Option?Zacks X

2 days The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and RyanairZacks X

2 days Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EUZacks X

3 days Pfizer names oncology head Chris Boshoff as R&D chiefInvesting.com X

3 days Pfizer names oncology chief and company veteran Boshoff as chief scientific officerMarketWatch X

3 days Pfizer Names New R&D ChiefThe Wall Street Journal X

3 days Is It Time to Sell Eli Lilly and Pfizer Stocks?The Motley Fool X

3 days Is It Time to Sell Eli Lilly and Pfizer Stocks?Yahoo Finance X

4 days Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rulesYahoo Finance X

4 days The Zacks Analyst Blog Highlights Pfizer, Newmont, Uber, Adobe and QualcommZacks X

5 days Jim Cramer on Pfizer Inc. (PFE): ‘Still, Anything Good There, It Could Fly’Insider Monkey X

1 week Pfizer- am I stuck with take lock or is this a great value?Reddit X

1 week Pfizer (PFE) is a Top-Ranked Value Stock: Should You Buy?Zacks X

1 week Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretaryFast Company X

1 week Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHSInvestor's Business Daily X

1 week Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

1 week Court Hears New York Times Case Against European Commission Over Vaccine DealThe New York Times X

1 week Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHSMarketWatch X

1 week Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHSCNBC X

1 week Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS?Investor's Business Daily X

1 week Is Pfizer Inc. (PFE) Among The Top Dividend Contenders Right Now?Insider Monkey X

1 week The Oncology Bet Is Already Paying Off For PfizerYahoo Finance X

1 week Pfizer Inc. (PFE) UBS Global Healthcare Conference (Transcript)Seeking Alpha X

1 week Zacks.com featured highlights include StoneCo, Skechers, Pfizer and General MotorsZacks X

2 weeks 3 Stocks Seeing Insider Buys: CNC, PFE, BMYZacks X

2 weeks Exclusive-Pfizer explores sale of hospital drugs unit, sources sayYahoo Finance X

2 weeks Should Value Investors Buy Pfizer (PFE) Stock?Zacks X

2 weeks AbbVie And Pfizer: Q3 Dividend Checkup Post-EarningsSeeking Alpha X

2 weeks Pfizer Inc. (PFE): Among the Best Low Volatility Stocks to Invest In NowInsider Monkey X

2 weeks 3 Reasons Pfizer Looks Like a No-Brainer Buy Right NowThe Motley Fool X

3 weeks PFE or NVO: Which Is the Better Value Stock Right Now?Zacks X

3 weeks 1 Green Flag That’s Also a Red Flag for Pfizer StockThe Motley Fool X

3 weeks Buy, Sell or Hold Pfizer Stock After Q3 Earnings Beat, Guidance Boost?Zacks X

3 weeks Is Pfizer Stock a Bargain for Long-Term Investors?The Motley Fool X

3 weeks This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?The Motley Fool X

3 weeks 3 Potential Catalysts That Could Lift Pfizer Stock Before 2025The Motley Fool X

3 weeks Pfizer Is A Good Stock To Buy After The EarningsSeeking Alpha X

3 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X

3 weeks Pfizer Inc. (NYSE:PFE) Director Acquires $28,240.00 in StockMarketBeat X

3 weeks Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying?Yahoo Finance X

3 weeks Pfizer (NYSE:PFE) Stock Price Down 0.4% – Should You Sell?MarketBeat X

3 weeks Pfizer CEO discusses Q3 earnings, ‘exceptional’ growthYouTube X

3 weeks Zacks Investment Ideas feature highlights: Pfizer, Philip Morris and Tenet HealthcareZacks X

3 weeks 3 Factors That Make Pfizer’s Ultra-High-Yield Dividend Safer Than You Might ThinkThe Motley Fool X

3 weeks Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily X

3 weeks Pfizer (NYSE:PFE) Stock Price Down 0.7% – Here’s What HappenedMarketBeat X

3 weeks 3 Stocks to Buy Following Robust Quarterly ResultsZacks X